Biotechnology companies have led the way in the initial public offering (IPO) market for the past four years. Yet only 17 of the 225 IPOs were led by female CEOs, 4 of whom are women of color. Lack of gender and racial diversity in company leadership can have implications for long-term success.
© 2017 Association for Women in Science. All Rights Reserved.